Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132608) titled 'A Study on the Efficacy of Sivelestat Sodium in the Treatment of Sepsis Patients with ARDS' on Sept. 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ganzhou People's Hospital
Condition:
Elderly patients with sepsis complicated by ARDS
Intervention:
Intervention Group:A daily dose (4.8 mg/kg) of sivelestat sodium for injection (lyophilized powder) is diluted in 48 mL of normal saline and administered by continuous intravenous infusion over 24 hours (2 mL/h, equivalent to 0.2 mg/kg/h). During treatment with sivelestat sodium, the patient's routine treatment regimen is not affect...